| Alimta® or with Platinol® Benefits Patients with Recurrent Mesothelioma
According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta® (pemetrexed) with or without the chemotherapy agent Platinol® (cisplatin) provides benefit for patients with malignant mesothelioma who have received prior therapies. Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. It is often caused by chronic exposure to asbestos. The majority of patients are not diagnosed until the disease has progressed to an advanced stage and treatment with surgery or radiation is not an option. Patients with this disease often experience symptoms, such as shortness of breath, cough, pain, fatigue, and an inability to eat, which lessen their quality of life.
(AFX UK Focus) 2006-07-20 12:37 GMT: UK govt streamlining claims handling for asbestos compensation claims
LONDON (AFX) - The government said it is introducing immediate measures to help victims of asbestos-related lung cancer get their compensation claims handled faster. Work and Pensions Secretary John Hutton said the interim action will include clarifying with claims handlers "best practice to ensure priority is given to those with mesothelioma", the medical name for the disease. "We will also work with Revenue and Customs so that employer records can be traced quicker," he said. The move comes on top of the government's decision to change the law through the Compensation Bill, in light of a Law Lords ruling which would have caused delays in resolving claims and made it more difficult for sufferers to recover full compensation. newsdesk@afxnews.com fp/joy COPYRIGHT Copyright AFX News Limited 2005.
APIL: Compensation bill gets royal assent
We applaud the Government for introducing long overdue regulation of claims management companies but we must ensure the new rules provide robust protection for injured people. A great injustice has also been rectified following a Herculean effort by the Government to reverse the ruling in the Barker case, which would have been disastrous for mesothelioma sufferers. This swift action is to be commended. We fought vehemently alongside others for clause 1 of the bill, the so-called ‘negligence' clause, to be removed. We believe it will provide a bigger safety net for negligent defendants and erode standards of safety, but we must now wait and see how the courts interpret “desirable activities," and the impact this will have on compensation for injured people." -ends- For more information, contact: Lisa Wardle, t: 01159388715 or Lorraine Gwinnutt, t: 0115 9388707 .
Renouned Economist Louis Winnick Dead
Louis Winnick, an economist who helped guide the investments of the Ford Foundation and promoted low-income home ownership, has died. He was 85. Winnick died Saturday at a hospice in Manhasset, on Long Island. The cause of death was mesothelioma, a type of lung cancer that his daughter Pamela Winnick attributed to exposure to asbestos when he worked in the Brooklyn Navy Yard during World War II. Winnick was born in Romania and came to Brooklyn when he was one year old. He graduated from Brooklyn College and earned graduate degrees in economics at Columbia University. He worked for the New York City Planning Commission and the Housing and Redevelopment Board before joining the Ford Foundation in 1962. He served as deputy vice president in the national affairs division from 1968 to 1986. Winnick played a major role in the foundation's effort to channel resources into housing, community renewal and minority enterprise following the turbulence of the late 1960s.
|
